Endometrioma Clinical Trial
— SOAVE-1Official title:
Comparison Between Suture of the Ovary Versus no Suture After Enucleation of Ovarian Endometrioma
NCT number | NCT03788720 |
Other study ID # | SOAVE-1 |
Secondary ID | |
Status | Not yet recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | May 2023 |
Est. completion date | May 2027 |
Endometriosis is an estrogen-dependent chronic disease, characterized by the presence of ectopic endometrial-like tissue outside the uterine cavity. According to the most updated guidelines of the European Society of Human Reproduction and Embryology (ESHRE), infertile women with endometriomas smaller than 3 cm should be addressed directly to Assisted Reproduction Technology (ART); conversely, for infertile women with endometriomas larger than 3 cm, enucleation of ovarian endometriomas could be considered in order to improve reproductive outcomes (both spontaneous and ART pregnancy rate). To date, literature data do not allow to draw a firm conclusion about the best strategy to reduce ovarian damage during enucleation of ovarian endometriomas: in particular, investigators still lack robust evidence in order to choose between suturing the ovary or not after the enucleation. In this scenario, the aim of our the study will be to compare functional outcomes of the ovary in a group of women undergoing suturing of the ovarian cortex after laparoscopic enucleation of endometriomas (cases) and a group of women undergoing laparoscopic enucleation of endometriomas without subsequent suture of the ovarian cortex.
Status | Not yet recruiting |
Enrollment | 100 |
Est. completion date | May 2027 |
Est. primary completion date | May 2025 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 35 Years |
Eligibility | Inclusion Criteria: - Women affected by one primary (no recurrent) monolateral ovarian endometrioma, with maximum diameter between 5 and 10 cm, undergoing laparoscopic enucleation by stripping technique; - Normal AFC at the enrollment (baseline). Exclusion Criteria: - Any other disease; - Bilateral endometriomas; - Deep infiltrating endometriosis; - No previous pelvic surgery (even not gynecological); - Any other pharmacologic and non pharmacologic treatment in the previous 3 months (wash-out period); |
Country | Name | City | State |
---|---|---|---|
Italy | "Filippo Del Ponte" Hospital | Varese |
Lead Sponsor | Collaborator |
---|---|
Università degli Studi dell'Insubria |
Italy,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Antral Follicle Count (AFC) | AFC will be evaluated on day 3 of the cycle by a transvaginal ultrasound. Initially the ovarian volume of both the ovaries is calculated. Further the number of small antral follicles in both the ovaries is measured. These follicles could vary in size from 2-10 mm. | Change from day 3 of the menstrual cycle prior to the elective laparoscopic surgery to day 3 of the menstrual cycle after to the elective laparoscopic surgery | |
Secondary | Pulsatility index, evaluated by Doppler flowmetry, of the ovarian artery | Evaluation of the pulsatility index (PI; minimum: 0; maximum: 7; higher values represent a better outcome) of the ovarian artery. | Change from day 3 of the menstrual cycle prior to the elective laparoscopic surgery to day 3 of the menstrual cycle after to the elective laparoscopic surgery | |
Secondary | Resistive index, evaluated by Doppler flowmetry, of the ovarian artery | Evaluation of the resistive index (RI minimum: 0; maximum: 3; higher values represent a worse outcome) of the ovarian artery. | Change from day 3 of the menstrual cycle prior to the elective laparoscopic surgery to day 3 of the menstrual cycle after to the elective laparoscopic surgery | |
Secondary | Ovarian volume | Evaluation of the ovarian volume calculated using the prolate ellipsoid formula (length x height x width x 0.523) | Change from day 3 of the menstrual cycle prior to the elective laparoscopic surgery to day 3 of the menstrual cycle after to the elective laparoscopic surgery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01268930 -
Comparison of Hemostatic Matrix and Bipolar Coagulation in Surgical Treatment of Endometriomas
|
N/A | |
Completed |
NCT05323539 -
Comparison of Thyroid Volumes in Patients With and Without Endometrioma
|
N/A | |
Recruiting |
NCT04178876 -
Comparison of Laparoscopic Endometrioma Stripping Versus Ethanol Sclerotherapy( CLESS)
|
N/A | |
Completed |
NCT06421857 -
Hemostatic Measures During Laparoscopic Cystectomy for Endometrioma
|
N/A | |
Recruiting |
NCT04151433 -
Conservative Endometrioma Surgery
|
N/A | |
Completed |
NCT01942122 -
DLBS1442 for The Treatment of Pain in Patients Suspected Endometriosis
|
Phase 2/Phase 3 | |
Withdrawn |
NCT00999479 -
Post Operative Continuous Active Combination Sex Steroids for the Prevention of Recurrent Endometrioma Formation
|
N/A | |
Recruiting |
NCT03687398 -
Genomic Maps of Endometrial Tissues of Patients With Endometriosis and Healthy Controls
|
||
Not yet recruiting |
NCT06377553 -
PET/MRI for Evaluation of Endometriosis
|
||
Completed |
NCT01982526 -
Role of Anti Mullerian Hormone for Ovarian Reserve Determination of Preoperative and Postoperative Endometrioma Patients
|
||
Recruiting |
NCT05962775 -
Ethanol Sclerotherapy Prior to ART
|
N/A | |
Completed |
NCT03484546 -
Optimum Menstrual Cycle Time for Endometrioma Excision
|
||
Completed |
NCT01808170 -
Laparoscopic Ovarian Cystectomy of Endometrioma vs Deroofing and Ovarian Reserve
|
N/A | |
Recruiting |
NCT05637073 -
Effect of Management of the Endometrioma on Ovarian Reserve
|
||
Completed |
NCT06219044 -
Evaluation of Ovarian Reserve and Recurrence Rate After DWLS Diode Laser OMA Vaporization
|
N/A | |
Recruiting |
NCT03620838 -
Endometrioma Per se Versus Treatment Related Reduction in Ovarian Reserve (ERROR-2 Trial)
|
||
Terminated |
NCT03571776 -
Anti-mullerian Hormone (AMH) After Treatment of Endometriomas With Alcohol Sclerotherapy Versus Surgery: Clinical Trial
|
N/A | |
Enrolling by invitation |
NCT02472873 -
Efficacy of Aspiration and Sclerotherapy During Laparoscopy Using 95% Ethanol for the Treatment of Endometriomas
|
N/A | |
Completed |
NCT04941833 -
Desogestrel for the Preoperative Treatment of Endometrioma Compared With Placebo
|
Phase 2/Phase 3 | |
Completed |
NCT06274086 -
Two-session Catheter-directed Sclerotherapy Using Ethanol for Endometrioma
|
N/A |